Marriott Harrison advises Frontline Ventures on its investment into Overwatch Research

Tuesday 26th October, 2021

Marriott Harrison advised Frontline Ventures on its seed investment into Overwatch Research, a Belfast-based company that has developed a management software platform used in preclinical trials. The platform encompasses preclinical research workflows for study design, data collection, data analysis and reporting, allowing researchers to operate more efficiently.

The total investment round was $3.5 million and was led by Frontline Ventures. Other prominent investors included SV Angel, Flatiron Health co-founder Zach Weinberg, the Parker Institute for Cancer immunology co-founder Michael Polansky, and Robert Fenton, chief executive of Qualio.

Overwatch Research intends to use the financing to fuel its expansion in the US to meet demand for improved laboratory research processes. It is also intending to create 18 new jobs.

The team at MH was led by Corporate partner David Strong with assistance from Corporate associate James Fleming.